Similar articles

• [Radiochemotherapeutic options for bladder cancer].

  Weiss C, Sauer R, Rödel C. Weiss C, et al. Aktuelle Urol. 2008 Mar;39(2):123-9. doi: 10.1055/s-2008-1038150. Aktuelle Urol. 2008. PMID: 18379965 Review. German.
• The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.

  Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. Lambert EH, et al. BJU Int. 2007 Jul;100(1):33-6. doi: 10.1111/j.1464-410X.2007.06912.x. BJU Int. 2007. PMID: 17552951
• Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations.

  Klaassen Z, Kamat AM, Kassouf W, Gontero P, Villavicencio H, Bellmunt J, van Rhijn BWG, Hartmann A, Catto JWF, Kulkarni GS. Klaassen Z, et al. Eur Urol. 2018 Nov;74(5):597-608. doi: 10.1016/j.eururo.2018.06.024. Epub 2018 Jul 13. Eur Urol. 2018. PMID: 30017405
• Perioperative chemotherapy: when to use it, what to use, and why.

  Johnson DC, Pruthi RS, Woods ME. Johnson DC, et al. Urol Clin North Am. 2013 May;40(2):183-95. doi: 10.1016/j.ucl.2013.01.001. Epub 2013 Feb 28. Urol Clin North Am. 2013. PMID: 23540777
• Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial.

  Oh KS, Soto DE, Smith DC, Montie JE, Lee CT, Sandler HM. Oh KS, et al. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):511-7. doi: 10.1016/j.ijrobp.2008.08.021. Epub 2008 Oct 30. Int J Radiat Oncol Biol Phys. 2009. PMID: 18977098 Clinical Trial.